A Phase III Study of an Otic Formulation in Acute Otitis Media With Tympanostomy Tubes
Phase 3
Completed
- Conditions
- Acute Otitis Media
- Interventions
- First Posted Date
- 2007-12-21
- Last Posted Date
- 2012-12-03
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 911
- Registration Number
- NCT00578474
A Phase II Study of an Otic Formulation in Treating Peri-Operative Tube Otorrhea
Phase 2
Completed
- Conditions
- Acute Otitis Media
- Interventions
- First Posted Date
- 2007-12-21
- Last Posted Date
- 2012-12-03
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 303
- Registration Number
- NCT00578773
Phase III Study of an Otic Formulation in Acute Otitis Media With Tympanostomy Tubes
Phase 3
Completed
- Conditions
- Acute Otitis Media
- Interventions
- First Posted Date
- 2007-12-21
- Last Posted Date
- 2012-12-03
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 776
- Registration Number
- NCT00579189
Safety and Efficacy of Olopatadine HCl Nasal Spray in 6-11 Year Old Patients
Phase 3
Completed
- Conditions
- Seasonal Allergic Rhinitis
- Interventions
- Drug: Vehicle
- First Posted Date
- 2007-12-21
- Last Posted Date
- 2010-03-02
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 2388
- Registration Number
- NCT00578929
- Locations
- 🇺🇸
Kenilworth/IL, Kenilworth, Illinois, United States
TOBRADEX Ophthalmic Suspension Versus Tobramycin 0.3%/Dexamethasone 0.05% Ophthalmic Suspension
Phase 3
Completed
- Conditions
- Ocular Inflammation Associated With Blepharaconjunctivitis
- Interventions
- First Posted Date
- 2007-12-19
- Last Posted Date
- 2010-03-02
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 221
- Registration Number
- NCT00576251
- Locations
- 🇺🇸
Houston, Houston, Texas, United States
Patient Preference Study
Phase 3
Completed
- Conditions
- GlaucomaOcular Hypertension
- Interventions
- Drug: AL-3862+timolol ophthalmic suspensionDrug: Dorzolamide+timolol ophthalmic solution
- First Posted Date
- 2007-12-19
- Last Posted Date
- 2014-07-11
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 129
- Registration Number
- NCT00576342
Acute Comfort and Blur of Systane and Optive
Not Applicable
Completed
- Conditions
- Dry Eye
- Interventions
- Other: Optive Lubricant Eye DropsOther: Systane Lubricant Eye Drops
- First Posted Date
- 2007-12-06
- Last Posted Date
- 2012-02-02
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 40
- Registration Number
- NCT00568386
Safety and Efficacy of Vitreous Delineating Agent During Vitrectomy
Phase 3
Completed
- Conditions
- Vitrectomy
- Interventions
- First Posted Date
- 2007-09-20
- Last Posted Date
- 2012-04-05
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 60
- Registration Number
- NCT00532415
A Single Dose Comfort Comparison of Travatan Z in One Eye Versus Xalatan in the Opposite Eye in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension
Phase 4
Completed
- Conditions
- Open-Angle GlaucomaOcular Hypertension
- Interventions
- First Posted Date
- 2007-09-11
- Last Posted Date
- 2012-05-18
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 54
- Registration Number
- NCT00527592
IOP Lowering Efficacy of Travoprost/Brinzolamide Fixed Combination Ophthalmic Suspension in Patients With Open-Angle Glaucoma or Ocular Hypertension
Phase 2
Completed
- Conditions
- Open-angle GlaucomaOcular Hypertension
- First Posted Date
- 2007-09-11
- Last Posted Date
- 2012-04-16
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 136
- Registration Number
- NCT00527501
- Locations
- 🇺🇸
Artesia, Artesia, California, United States
© Copyright 2025. All Rights Reserved by MedPath